Tag:
Vaxart
Latest Headlines
Latest Headlines
Vaxart starts Ph1 oral vax trial
San Francisco-based Vaxart has started dosing patients in its first Phase I trial using its oral vaccine platform. The study uses an H5N1 flu vaccine, but the platform, if effective, could be used
Vaxart lands $12.5M round, readies Phase I trial
The San Francisco start-up Vaxart has banked a $12.5 million Series B venture round, with the money going to support its work building a portfolio of orally-delivered vaccines. Care Capital of
